Physics Approaches to the Spatial Distribution of Immune Cells in Tumors
Clare C. Yu, Juliana C. Wortman, Ting-Fang He, Shawn Solomon, Robert, Z. Zhang, Anthony Rosario, Roger Wang, Travis Y. Tu, Daniel Schmolze, Yuan, Yuan, Susan E. Yost, Xuefei Li, Herbert Levine, Gurinder Atwal, and Peter P., Lee

TL;DR
This paper introduces a maximum entropy method to analyze the spatial distribution of immune cells in tumor tissues, revealing its significance in predicting cancer recurrence and improving immunotherapy strategies.
Contribution
The study applies a novel maximum entropy approach to quantify immune cell spatial distribution, linking it to clinical outcomes in breast cancer patients.
Findings
Distinct spatial distributions correlate with clinical outcomes
Spatial distribution analysis improves recurrence prediction
Immune cell arrangement impacts immunotherapy effectiveness
Abstract
The goal of immunotherapy is to enhance the ability of the immune system to kill cancer cells. Immunotherapy is more effective and, in general, the prognosis is better, when more immune cells infiltrate the tumor. We explore the question of whether the spatial distribution rather than just the density of immune cells in the tumor is important in forecasting whether cancer recurs. After reviewing previous work on this issue, we introduce a novel application of maximum entropy to quantify the spatial distribution of discrete point-like objects. We apply our approach to B and T cells in images of tumor tissue taken from triple negative breast cancer (TBNC) patients. We find that there is a distinct difference in the spatial distribution of immune cells between good clinical outcome (no recurrence of cancer within at least 5 years of diagnosis) and poor clinical outcome (recurrence within 3…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
